Thrombolytic therapy for patients with acute ischemic stroke: systematic review and network meta-analysis of randomized trials
ObjectiveTo systematically compare the benefits and risks of all thrombolytic agents (tenecteplase, reteplase, and alteplase) at different doses for thrombolytic therapy in patients with acute ischemic stroke (AIS).BackgroundAlteplase is the cornerstone treatment for AIS, but alternative thrombolyti...
Saved in:
Main Authors: | Li-Chao-Yue Sun, Wen-Shu Li, Wei Chen, Zhao Ren, Chun-Xing Li, Ze Jiang, Le Wang, De-Li Wang, Qing Xie |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2024.1490476/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risk of angioedema and thrombolytic therapy among stroke patients: An analysis of data from the FDA Adverse Event Reporting System database
by: Hunong Xiang, et al.
Published: (2025-01-01) -
Safety of tenecteplase vs. alteplase in telestroke: a large multistate experience (STAT)
by: Morgan Figurelle, et al.
Published: (2025-01-01) -
Efficacy of Intravenous Tenecteplase Bridge Thrombectomy for Recurrent Ischemic Stroke Within 3 Months: A Case Report
by: Liu C, et al.
Published: (2025-02-01) -
Comparison of the safety and efficacy of dual antiplatelet therapy versus tenecteplase in patients with minor nondisabling acute ischemic stroke
by: Xinzhao Jiang, et al.
Published: (2025-01-01) -
替奈普酶治疗急性缺血性卒中的研究进展及展望 Research Progress and Prospect of Tenecteplase in the Treatment of Acute Ischemic Stroke
by: 徐露,董漪,董强 (XU Lu, DONG Yi, DONG Qiang)
Published: (2025-01-01)